Deficiência aguda de tiamina: Efeitos no crescimento e resposta quimioterápica de um fibro-histiocitoma maligno de rato

Autores

  • Paulo Schor Faculdade de Medicina de Ribeirão Preto. Universidade de São Paulo (USP), Ribeirão preto (SP), Brasil
  • Ronaldo A. Ribeiro Universidade Federal do Ceará (UFC) Fortaleza (CE), Brasil
  • Sérgio Zucoloto Faculdade de Medicina de Ribeirão Preto. Universidade de São Paulo (USP), Ribeirão preto (SP), Brasil

DOI:

https://doi.org/10.32635/2176-9745.RBC.1990v36n1/4.3117

Palavras-chave:

Deficiência Aguda em Tiamina, Fibro-Histiocitoma Maligno, Quimioterapia

Resumo

Os objetivos do presente trabalho foram estudar os efeitos da deficiência aguda de tiamina no crescimento e na resposta quimioterápica de um fibro-histiocitoma maligno no rato. Para tanto, ratos foram inoculados por via subcutânea com suspensão de células tumorais e divididos em quatro grupos, de 10 animais cada: DCT - alimentados com dieta sem tiamina; DVC - alimentados com dieta sem tiamina e tratados com sulfato de vincristina (SVC); TGT - Alimentados com dieta-controle; e TVC - alimentados com dieta-controle e tratados com SVC. Os animais tratados com SVC (DVC e TVC) apresentaram diminuição de volume tumoral quando comparados com os não tratados (DCT e TCT). Entretanto, não houve alteração no volume tumoral de animais carentes em tiamina e tratados (DVC) em relação àqueles tratados e com dieta-controle (DCT). Estes dados indicam que a deficiência aguda de tiamina per se não altera o crescimento do FHM como também não modifica a resposta do tumor frente à quimioterapia com SVC.

Downloads

Não há dados estatísticos.

Referências

FARMER PB. Cancer chemotherapy I: Design and mechanism of action cytotoxic drugs. In: Farmer PB, and Walker JM (Editors), The molecular basis of cancer. Croom Heim, London and Sydney 1985: 259-286. DOI: https://doi.org/10.1007/978-1-4684-7313-1_10

VINCENT MD. The clinical problem: In Farmer PB and Walker JM. (Editors). The Molecular Basis of Cancer. Croom Helm, London and Sydney, 1985: 1-236.

BRISTRIAN RR, BLACKBURN GL, VITLATLE J, COCHRAN D, NAYLOR J. Prevalence of malnutrition in general medical patients. Journal American Medical Association 1976; 235: 1567-1570. DOI: https://doi.org/10.1001/jama.235.15.1567

WEINSIER RL, HUNKER EM, KRUNDIECK CL, RUTTERWORD CE. A prospective evaluation of general medical patients during the course of hospitalization. American Journal of Clinical Nutrition, 1979; 32: 418-426. DOI: https://doi.org/10.1093/ajcn/32.2.418

LEEVY CM, CARDI L, FRANK O, GELLENE R, BECKER H. Incidence and significance of hypovitaminemia in a randomly selected municipal hospital population. American Journal of Clinical Nutrition 1965; 17: 259-271. DOI: https://doi.org/10.1093/ajcn/17.4.259

CIPRIANO TC, ZUCOLOTO S, MUCCILLO G. Acute thiamin deficiency: a morphometric and cell proliferation study of jejunum epithelial cell. International Journal for Vitamin and Nutrition Research 1987: 151-154.

KOVACEVIC Z AND McGlVAN JD. Mitochondrial metabolism of glutamine and glutamate and its physiological significance. Physiological Reviews 1983; 63: 547-605. DOI: https://doi.org/10.1152/physrev.1983.63.2.547

THOMLINSON RH, GRAY LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. British Journal of Cancer 1955; 9: 539-549. DOI: https://doi.org/10.1038/bjc.1955.55

GOLDACRE RJ, SYLVEN B. On the accessofblood-borne dyes to various tumor regions. British Journal of Cancer 1962; 16: 306-322. DOI: https://doi.org/10.1038/bjc.1962.36

GULLENO PM. The internal milieu of tumors. Progress of Experimental Tumor Research 1966; 8: 1-25. DOI: https://doi.org/10.1159/000386002

TANNOCK IF. The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumor. British Journal of Cancer 1968; 22: 258-273. DOI: https://doi.org/10.1038/bjc.1968.34

RIBEIRO RA, BEZERRA DE ARAÚJO RW, FONTELES MC, FERREIRA FVA, ZUCOLOTO S, ROSSI MA. Tumor fibrohistiocltico (TEGS-2047) transplantável em ratos Wistar - Histopatologia, ultra-estrutura, citoquímica enzimática e potencial metastático. Rev Bras Cancerol 1986a; 32(2): 159.

RIBEIRO RA, ZUCOLOTO S, CIPRIANO TC, LEITÃO MC, FONTELES MC. Tumor fibro-histiocítico (TEGS-2047) transplantável em ratos Wistar - Estudo cinético com bloqueador de mitose. Rev Bras Cancerol 1986b; 32(2): 160.

RIBEIRO RA, FONTELES MC, ZUCOLOTO S, BACCHI CE. lmunohistochemical identification of lysozyme and Vimentin in na experimental malignant fibrous histiocytoma. Brazilian J Med Biol Aos 1988; 21: 995-997.

HENDERSON GI, DILLON M, SCHENKER S. Effect of diet-induced thiamine deficiency on visceral DNA synthesis and tissue composition. Biochem Pharmacol 1976; 25: 2275-2284. DOI: https://doi.org/10.1016/0006-2952(76)90010-1

PAUL F. CeIl on tissue culture. Churchill Livingstone, New York 1975; 219-231.

STEEL GG. Growth kinetics of tumors. Clarendon Press, Oxford 1977: 5-55.

FÉAUX DE LACROIX W, WEYER M, SCHULT A, LENNARTZ KJ. Age-dependent change of the effect of a cytostatic during on the proliferation kinetics of a solid tumours of the mouse. Journal Cancer Research Clinical Oncology 1979; 94: 29-35. DOI: https://doi.org/10.1007/BF00405347

ARAÚJO RWB, ZUCOLOTO S, FERREIRA FVA, CIPRIANO TC, MELLO DE OLIVEIRA, ROSSI MA CONACCHIONI ALB. Estrutura, perfil histoquímico e comportamento biológico de tumor espontâneo da região da glândula salivar de rato (TEGS-2047). Anais do XVI Congresso Brasileiro de Patologia, 1985; pág. 131.

PEDERSON PL. Tumor mitochondrial and the bioenergetics of cancer cells. Progress Experimental Tumor Research 1978; 22: 190-274. DOI: https://doi.org/10.1159/000401202

RIVERA S, LÓPEZ-SORRANO FJ, AZCON-BIETS J, ARGILES JM. Blood amino acid compartmentation in mico bearing lewis lung carcinoma. Cancer Research 1987; 47: 5644-5646.

CURRIE G, CURRIE A. Cancer the biology of malignant disease. Castlefield Press. Northhampton, England 1982; pp. 39.

CLARCK CM, GOODLAD GAC. Depletion of protein of phasic and tonic muscle in tumor bearing rata. European Cancer 1971; 7:3-9. DOI: https://doi.org/10.1016/0014-2964(71)90088-0

KOVACEVIC Z. Properties and intracellular localizations of Ehrlich ascites tumor cells glutamirrase. Cancer Research 1974: 34: 3403-3407.

LAZO PA. Tumor induction of host leucine starvatiori. FEBS Letters, 1981; 229-231. DOI: https://doi.org/10.1016/0014-5793(81)80788-0

CARRASCOSA JM, MARTINS P AND NUIJEZ DE CASTRO I. Mtrogen movement between host and tumor in mice inoculated with Ehrlich ascitic tumor celis. Cancer Research 1984; 44: 3831-3835.

HAYES KC. Taurine in metabolism. Annual Review of Nutrition 1986; 1:401-425. DOI: https://doi.org/10.1146/annurev.nu.01.070181.002153

LAVIETES BB, REGAN DH, DEMOPOULOS HB. Glutamate oxidation in 6C31-1ED Iymphoma: Effects of L-asparaginase on sensitive and resistant lines. Proceedings National Academy of Sciences 1974; 71: 3993-3997. DOI: https://doi.org/10.1073/pnas.71.10.3993

REITZER LJ, WICE BM AND KENNELL D. Evidence that glutamine, not sugar is the major energy source for cultured HeLa cells. Journal of Biological Chemistry 1979; 254: 2669-2676. DOI: https://doi.org/10.1016/S0021-9258(17)30124-2

CAMPLEJOHN RS, SCHULTZE B, MAVRER W. An in vivo double Iabelling study of the subsequent fate of celis arrested in metáfase by vincristine in the J .B. 1 mouse ascites tumor. CeUs Tissue Kinetic 1980; 13: 239-245. DOI: https://doi.org/10.1111/j.1365-2184.1980.tb00463.x

FÉAUX DE LACROIX W, MALLMAN H. Comparative investigatioris on the effect of different dose schedules of the phase-specific during vincristine (VCR) on the proliferation kinetics of a solid experimental tumour. Cell Tissue Kinetic 1984: 583-591. DOI: https://doi.org/10.1111/j.1365-2184.1984.tb00617.x

OWELLEN RJ, OWENS AH JR., DONIGIAN DW. The bindings of vincristine, vinblastine and coichicirre to tubulin. Biochemical and Biophysical Research Community 1972; 47: 685-691. DOI: https://doi.org/10.1016/0006-291X(72)90546-3

OWELLEN RJ, HARTKE CA, DICKERSON RM, HAINS FO. Inhibition of tubulin-microtubule polymenzation by drugs of the vinca alkaloid class. Cancer Research 1976; 36: 1499-1502.

CREASEY WA. Modifications in biochemical patways produced by the vinca alkaloids. Cancer Chemotherapic 1968; 52: 501-507.

WAGNER EK, ROIZMAN B. Effects of the vinca alkaloids on ANA synthesis in human in vivo. Science 1968; 162: 569-570. DOI: https://doi.org/10.1126/science.162.3853.569

RICHARDS JF. Biochemical studies with the vinca alkaloids. Cancer Chemotherapic Report 1968; 52: 463-467.

Howards SMH, Theologides A and Sheppard JR. Comparative effects of vindesine, vinblastina and vincristine on mitotic arrest and hormonal response of L1210 Ieukemia cells. Cancer Research 1980; 40: 2695-2700.

SEPPARD JA. Effects of vinca alkaloids on cyclic AMP metabolismo of mouse splenic lymphocytes. Contribution of Oncology 1980; 6: 27-36. DOI: https://doi.org/10.1159/000428614

BECK WT. Increase by vinblastine of oxidized glutathiorre in cultured mammalian celis. Biochemistry Pharmacology 1980; 29: 2333-2337. DOI: https://doi.org/10.1016/0006-2952(80)90266-X

GIETZAN K, WUTRICH A, BODER H. Effects of microtubular inhibitors on plasma membrane calmodullin-dependent CA2-transport ATPase. Molecular Pharmacology 1982; 22: 413-420.

Downloads

Publicado

2023-07-31

Como Citar

1.
Schor P, Ribeiro RA, Zucoloto S. Deficiência aguda de tiamina: Efeitos no crescimento e resposta quimioterápica de um fibro-histiocitoma maligno de rato. Rev. Bras. Cancerol. [Internet]. 31º de julho de 2023 [citado 28º de junho de 2024];36(1/4):37-41. Disponível em: https://rbc.inca.gov.br/index.php/revista/article/view/3117

Edição

Seção

ARTIGO ORIGINAL